174 related articles for article (PubMed ID: 22992116)
1. High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias.
Wu C; Jares A; Winkler T; Xie J; Metais JY; Dunbar CE
Hum Gene Ther; 2013 Jan; 24(1):38-47. PubMed ID: 22992116
[TBL] [Abstract][Full Text] [Related]
2. Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA.
Gabriel R; Kutschera I; Bartholomae CC; von Kalle C; Schmidt M
J Vis Exp; 2014 Jun; (88):e51543. PubMed ID: 24998871
[TBL] [Abstract][Full Text] [Related]
3. High-throughput genomic mapping of vector integration sites in gene therapy studies.
Beard BC; Adair JE; Trobridge GD; Kiem HP
Methods Mol Biol; 2014; 1185():321-44. PubMed ID: 25062639
[TBL] [Abstract][Full Text] [Related]
4. Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences.
Pule MA; Rousseau A; Vera J; Heslop HE; Brenner MK; Vanin EF
Cytotherapy; 2008; 10(5):526-39. PubMed ID: 18821360
[TBL] [Abstract][Full Text] [Related]
5. The LAM-PCR Method to Sequence LV Integration Sites.
Wang W; Bartholomae CC; Gabriel R; Deichmann A; Schmidt M
Methods Mol Biol; 2016; 1448():107-20. PubMed ID: 27317177
[TBL] [Abstract][Full Text] [Related]
6. Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples.
Schmidt M; Schwarzwaelder K; Bartholomae CC; Glimm H; von Kalle C
Methods Mol Biol; 2009; 506():363-72. PubMed ID: 19110638
[TBL] [Abstract][Full Text] [Related]
7. Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis.
Harkey MA; Kaul R; Jacobs MA; Kurre P; Bovee D; Levy R; Blau CA
Stem Cells Dev; 2007 Jun; 16(3):381-92. PubMed ID: 17610368
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primers.
Gentner B; Laufs S; Nagy KZ; Zeller WJ; Fruehauf S
Gene Ther; 2003 May; 10(9):789-94. PubMed ID: 12704418
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic access to vector integration in clinical gene therapy.
Gabriel R; Eckenberg R; Paruzynski A; Bartholomae CC; Nowrouzi A; Arens A; Howe SJ; Recchia A; Cattoglio C; Wang W; Faber K; Schwarzwaelder K; Kirsten R; Deichmann A; Ball CR; Balaggan KS; Yáñez-Muñoz RJ; Ali RR; Gaspar HB; Biasco L; Aiuti A; Cesana D; Montini E; Naldini L; Cohen-Haguenauer O; Mavilio F; Thrasher AJ; Glimm H; von Kalle C; Saurin W; Schmidt M
Nat Med; 2009 Dec; 15(12):1431-6. PubMed ID: 19966782
[TBL] [Abstract][Full Text] [Related]
10. Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource.
Peters B; Dirscherl S; Dantzer J; Nowacki J; Cross S; Li X; Cornetta K; Dinauer MC; Mooney SD
Gene Ther; 2008 Sep; 15(18):1294-8. PubMed ID: 18580967
[TBL] [Abstract][Full Text] [Related]
11. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.
Schmidt M; Hoffmann G; Wissler M; Lemke N; Müssig A; Glimm H; Williams DA; Ragg S; Hesemann CU; von Kalle C
Hum Gene Ther; 2001 May; 12(7):743-9. PubMed ID: 11339891
[TBL] [Abstract][Full Text] [Related]
12. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
13. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR).
Schmidt M; Schwarzwaelder K; Bartholomae C; Zaoui K; Ball C; Pilz I; Braun S; Glimm H; von Kalle C
Nat Methods; 2007 Dec; 4(12):1051-7. PubMed ID: 18049469
[TBL] [Abstract][Full Text] [Related]
14. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.
Daniel R; Smith JA
Hum Gene Ther; 2008 Jun; 19(6):557-68. PubMed ID: 18533894
[TBL] [Abstract][Full Text] [Related]
15. Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow.
Suryawanshi GW; Xu S; Xie Y; Chou T; Kim N; Chen ISY; Kim S
J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654067
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.
Arens A; Appelt JU; Bartholomae CC; Gabriel R; Paruzynski A; Gustafson D; Cartier N; Aubourg P; Deichmann A; Glimm H; von Kalle C; Schmidt M
Hum Gene Ther Methods; 2012 Apr; 23(2):111-8. PubMed ID: 22559057
[TBL] [Abstract][Full Text] [Related]
17. Isolation and analysis of retroviral integration targets by solo long terminal repeat inverse PCR.
Jin YF; Ishibashi T; Nomoto A; Masuda M
J Virol; 2002 Jun; 76(11):5540-7. PubMed ID: 11991982
[TBL] [Abstract][Full Text] [Related]
18. Integration of retroviral vectors.
Gabriel R; Schmidt M; von Kalle C
Curr Opin Immunol; 2012 Oct; 24(5):592-7. PubMed ID: 22981243
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput method for cloning and sequencing human immunodeficiency virus type 1 integration sites.
Kim S; Kim Y; Liang T; Sinsheimer JS; Chow SA
J Virol; 2006 Nov; 80(22):11313-21. PubMed ID: 16971446
[TBL] [Abstract][Full Text] [Related]
20. Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination.
Bergemann J; Kühlcke K; Fehse B; Ratz I; Ostertag W; Lother H
Nucleic Acids Res; 1995 Nov; 23(21):4451-6. PubMed ID: 7501469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
